Literature DB >> 19893007

Re: Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.

Sacha J Howell, Andrew M Wardley, Anne C Armstrong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19893007     DOI： 10.1093/jnci/djp390

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  7 in total

1.  Effects of G250 promoter controlled conditionally replicative adenovirus expressing Ki67-siRNA on renal cancer cell.

Authors:  Junjie Liu; Lin Fang; Qian Cheng; Liantao Li; Changqing Su; Baofu Zhang; Dongsheng Pei; Jie Yang; Wang Li; Junnian Zheng
Journal:  Cancer Sci       Date:  2012-08-10       Impact factor: 6.716

2.  Prognostic Value of Receptor Change After Neoadjuvant Chemotherapy in Breast Cancer Patients.

Authors:  Özlem Özdemir; Baha Zengel; Demet Kocatepe Çavdar; Cengiz Yılmaz; Raika Durusoy
Journal:  Eur J Breast Health       Date:  2022-04-01

3.  Erythropoietin-producing hepatocellular A6 overexpression is a novel biomarker of poor prognosis in patients with breast cancer.

Authors:  Danmei Zhou; Kehan Ren; Jigang Wang; Hong Ren; Wenlin Yang; Wenjuan Wang; Qiong Li; Xiuping Liu; Feng Tang
Journal:  Oncol Lett       Date:  2018-02-01       Impact factor: 2.967

4.  Preoperative Nomogram for Predicting Sentinel Lymph Node Metastasis Risk in Breast Cancer: A Potential Application on Omitting Sentinel Lymph Node Biopsy.

Authors:  Xi'E Hu; Jingyi Xue; Shujia Peng; Ping Yang; Zhenyu Yang; Lin Yang; Yanming Dong; Lijuan Yuan; Ting Wang; Guoqiang Bao
Journal:  Front Oncol       Date:  2021-04-26       Impact factor: 6.244

5.  Survival Analysis Based on Clinicopathological Data from a Single Institution: Chemotherapy Intensity Would Be Enhanced in Patients with Positive Hormone Receptors and Positive HER2 in China Who Cannot Afford the Target Therapy.

Authors:  Jianyi Li; Shi Jia; Wenhai Zhang; Yang Zhang; Xiang Fei; Rui Tian
Journal:  ISRN Oncol       Date:  2013-07-30

Review 6.  Atypical ubiquitin ligase RNF31: the nuclear factor modulator in breast cancer progression.

Authors:  Jian Zhu; Ting Zhuang; Huijie Yang; Xin Li; Huandi Liu; Hui Wang
Journal:  BMC Cancer       Date:  2016-07-26       Impact factor: 4.430

7.  Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer.

Authors:  Lee D Gibbs; Jamboor K Vishwanatha
Journal:  Oncotarget       Date:  2017-12-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.